JP2014521316A5 - - Google Patents

Download PDF

Info

Publication number
JP2014521316A5
JP2014521316A5 JP2014520314A JP2014520314A JP2014521316A5 JP 2014521316 A5 JP2014521316 A5 JP 2014521316A5 JP 2014520314 A JP2014520314 A JP 2014520314A JP 2014520314 A JP2014520314 A JP 2014520314A JP 2014521316 A5 JP2014521316 A5 JP 2014521316A5
Authority
JP
Japan
Prior art keywords
nucleic acid
pcr
different
library
primers
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014520314A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014521316A (ja
JP6731702B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2012/046431 external-priority patent/WO2013009967A2/en
Publication of JP2014521316A publication Critical patent/JP2014521316A/ja
Publication of JP2014521316A5 publication Critical patent/JP2014521316A5/ja
Application granted granted Critical
Publication of JP6731702B2 publication Critical patent/JP6731702B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014520314A 2011-07-12 2012-07-12 親和性成熟化ヒト抗体の同定 Active JP6731702B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161506749P 2011-07-12 2011-07-12
US61/506,749 2011-07-12
PCT/US2012/046431 WO2013009967A2 (en) 2011-07-12 2012-07-12 Identifying affinity-matured human antibodies

Publications (3)

Publication Number Publication Date
JP2014521316A JP2014521316A (ja) 2014-08-28
JP2014521316A5 true JP2014521316A5 (enExample) 2015-07-16
JP6731702B2 JP6731702B2 (ja) 2020-07-29

Family

ID=47506915

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014520314A Active JP6731702B2 (ja) 2011-07-12 2012-07-12 親和性成熟化ヒト抗体の同定

Country Status (11)

Country Link
US (6) US9234030B2 (enExample)
EP (2) EP3034513B1 (enExample)
JP (1) JP6731702B2 (enExample)
KR (1) KR102139388B1 (enExample)
CN (2) CN107090459A (enExample)
AU (2) AU2012281078B2 (enExample)
CA (1) CA2841475C (enExample)
IL (2) IL230358B (enExample)
MX (2) MX361600B (enExample)
RU (2) RU2636045C2 (enExample)
WO (1) WO2013009967A2 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2841475C (en) * 2011-07-12 2021-02-09 Xbiotech Inc. Identifying affinity-matured human antibodies
WO2014144495A1 (en) 2013-03-15 2014-09-18 Abvitro, Inc. Single cell bar-coding for antibody discovery
GB201316644D0 (en) * 2013-09-19 2013-11-06 Kymab Ltd Expression vector production & High-Throughput cell screening
US10533204B2 (en) 2014-05-30 2020-01-14 National University Corporatlon University of Toyama Method for amplifying a T cell receptor (TCR) cDNA
MX394895B (es) 2014-06-03 2025-03-24 Xbiotech Inc Composiciones útiles para el tratamiento de infecciones por staphylococcus aureus.
US10590483B2 (en) 2014-09-15 2020-03-17 Abvitro Llc High-throughput nucleotide library sequencing
US10975146B2 (en) 2018-06-29 2021-04-13 Cedars-Sinai Medical Center Interleukin-1 inhibition for combination treatment of pancreatic cancer
US12703882B2 (en) * 2019-06-14 2026-08-11 The Regents Of The University Of California Methods of sequencing antibody chains from hybridomas and kits for practicing same

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001068682A1 (en) 2000-03-10 2001-09-20 Large Scale Biology Corporation Self antigen vaccines for treating b cell lymphomas and other cancers
AU2002953381A0 (en) * 2002-12-18 2003-01-09 Diatech Pty Ltd In vivo affinity maturation scheme
WO2005017529A1 (en) * 2003-07-29 2005-02-24 Genentech, Inc. Assay for human anti cd20 antibodies and uses therefor
TWI333977B (en) 2003-09-18 2010-12-01 Symphogen As Method for linking sequences of interest
PE20071101A1 (es) 2005-08-31 2007-12-21 Amgen Inc Polipeptidos y anticuerpos
JP5205597B2 (ja) * 2007-06-01 2013-06-05 静岡県 1細胞レベルでの抗体遺伝子の解析・同定方法
RU2011117213A (ru) * 2008-09-30 2012-11-10 Эббот Лэборетриз (Us) Улучшенные библиотеки антител
CA2751669C (en) * 2009-02-20 2017-11-21 F. Hoffmann-La Roche Ag Method for obtaining immunoglobulin encoding nucleic acid
CA2841475C (en) * 2011-07-12 2021-02-09 Xbiotech Inc. Identifying affinity-matured human antibodies

Similar Documents

Publication Publication Date Title
CN112020562B (zh) 基于crispr效应系统的诊断
Gay et al. Mouse TU tagging: a chemical/genetic intersectional method for purifying cell type-specific nascent RNA
KR102514213B1 (ko) 면역 시냅스의 변이체 라이브러리 및 그의 합성
JP6608368B2 (ja) 核酸バーコードを用いた単一細胞と関連づけられた核酸の分析方法
JP7411016B2 (ja) 免疫レパートリー発掘
RU2014102617A (ru) Выявление аффинно-зрелых человеческих антител
CA3076518A1 (en) Crispr effector system based diagnostics
CN108368503A (zh) 用于受控dna片段化的方法
JP2015519076A5 (enExample)
JP2017514465A (ja) 核酸、特に長い核酸の合成方法、その方法の使用、および、その方法を実施するためのキット
JP2016500275A5 (enExample)
US11078478B2 (en) Methods of utilizing recombination for the identification of binding moieties
JP2013509878A5 (enExample)
JP7628153B2 (ja) mRNAディスプレイ抗体ライブラリー及び方法
JP2016533758A5 (enExample)
AU2020342793A1 (en) Method for sequencing RNA oligonucleotides
Liu et al. Complete genome sequence of Xanthomonas campestris pv. campestris strain 17 from Taiwan
US9797014B2 (en) Method of identifying VDJ recombination products
Raabe et al. The rocks and shallows of deep RNA sequencing: Examples in the Vibrio cholerae RNome
JP6522511B2 (ja) ヌクレオチド配列の確率指向性単離(pins)
Zheng et al. In-depth analysis of the genome of Trypanosoma evansi, an etiologic agent of surra
KR101648252B1 (ko) 염기서열 확인 과정에서 분리된 핵산 단편들을 회수하는 방법
JP2016500276A5 (enExample)
KR102593421B1 (ko) 다중 표적의 증폭을 위한 이량체 회피 다중 중합효소 연쇄 반응
JP6004423B2 (ja) 遺伝子連結法およびそれを用いた単鎖抗体作製方法